As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
Apollo continues to invest in genomics technology and research for better patient care
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
According to GlobalData’s analyst consensus forecast, OTX-2002 is projected to have the highest revenue by 2028, with sales of $1.6 billion during that year
Launch of Apollo Genomics Institutes would provide genetic counselling, tests, treatment and care for genetic disorders
Bempedoic Acid administered as a 180-mg dose, is approved by the USFDA and European Union for the treatment of hypercholesterolemia
Nulibry is approved by the U.S. Food and Drug Administration (USFDA) to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening paediatric genetic disorder
This test is inexpensive and results are available immediately as compared to the genetic test
Alnylam is the latest partner in the Medicines Manufacturing Innovation Centre’s third Grand Challenge project, which aims to revolutionise the manufacturing process for oligonucleotide therapies
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
